![Barbara Withers](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barbara Withers
Chief Tech/Sci/R&D Officer at OCUPHIRE PHARMA, INC.
Profile
Barbara Withers is currently the VP-Clinical & Regulatory Strategy at Ocuphire Pharma, Inc. Previously, she worked as a Project Director & Site Head at United BioSource Corp., a Project Manager-Drug Development at Pfizer Inc., and a Vice President-Clinical Operations at Aerpio Pharmaceuticals, Inc. Barbara received her undergraduate degree from the University of Michigan and her doctorate from The Wayne State University School of Medicine.
Barbara Withers active positions
Companies | Position | Start |
---|---|---|
OCUPHIRE PHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Barbara Withers
Companies | Position | End |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - |
United BioSource Corp.
![]() United BioSource Corp. Miscellaneous Commercial ServicesCommercial Services United BioSource Corp. is a scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. The company is involved in pre- and post-approval product development; pricing, coverage, reimbursement, and access strategies; and medical publication and communications. United BioSource Corp. was founded by Ethan D. Leder and Mark P. Cleinin in 2003 and is headquartered in Chevy Chase, MD. | Corporate Officer/Principal | - |
AERPIO PHARMACEUTICALS | Corporate Officer/Principal | - |
Training of Barbara Withers
The Wayne State University School of Medicine | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
OCUPHIRE PHARMA, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Private companies | 2 |
---|---|
Aerpio Pharmaceuticals, Inc.
![]() Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 16, 2007 and is headquartered in Cincinnati, OH. | Health Technology |
United BioSource Corp.
![]() United BioSource Corp. Miscellaneous Commercial ServicesCommercial Services United BioSource Corp. is a scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. The company is involved in pre- and post-approval product development; pricing, coverage, reimbursement, and access strategies; and medical publication and communications. United BioSource Corp. was founded by Ethan D. Leder and Mark P. Cleinin in 2003 and is headquartered in Chevy Chase, MD. | Commercial Services |
- Stock Market
- Insiders
- Barbara Withers